Does clopidogrel in addition to aspirin improve outcomes in patients with acute coronary syndromes without ST-segment elevation?
In patients with NSTE-ACS, adding clopidogrel to aspirin provides beneficial effects but increases the risk of major bleeding.
The antiplatelet agent clopidogrel has beneficial effects in patients with acute coronary syndromes without ST-segment elevation. However, the risk of major bleeding is increased among patients treated with clopidogrel.
Salim Yusuf (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: